Red c e l l volume reduction corrected t h e p l a t e l e t aggregat i o n abnormality and bleeding tendency exhibited by 4 boys, ages 5 t o 16, with severe cyanotic congenital h e a r t disease and polycythemia (Hcts 68-75%). Red c e l l volume was lowered by replacing 1 5 t o 20 ml/Kg of t h e p a t i e n t ' s blood with plasma i n 50 m l increments over a 1 t o 2 hour period. Within 3 days, p l a t e l e t aggregation was r e s t o r e d t o normal, and previous bleeding symptoms disappeared. P l a t e l e t aggregation remained normal during 3 weeks of follow-up while hematocrits remained a t p a l l i a t i v e l e v e l s . The procedure was safe, simple, and produced beneficial effects not only on bleeding, but,also on other symptoms r e l a t e d t o polycythemia and high blood viscosity.
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The mechanism by which p l a t e l e t function is corrected is not y e t understood. I n v i t r o s t u d i e s showed no c o r r e c t i v e e f f e c t s of donor plasma on t h e abnormal p l a t e l e t s .
For polycythemic p a t i e n t s with cyanotic h e a r t disease and p l a t e l e t defects who r e q u i r e surgery, red c e l l volume reduction is recommended preoperatively t o lessen t h e r i s k of s e r i o u s bleeding during t h e e a r l y postoperative period. P a l l i a t i o n of severely cyanotic children who a r e inoperable is another i n d i c a t i o n f o r t h i s procedure. An 1 I year old girl with aplastic anemia of unknown etiology was transplanted with MLC and HLA identical sibling marrow following 4 doses of Cyclophosphamide (CY) 50 mglkg. She had received multiple blood transfusions before transplantation (TP). Three weeks following TP the marrow was repopulating, but 4 weeks later the marrow was again aplastic. Immunosuppression with Procarbazine, anti-thymocyte globulin, and a repeat course of CY were given followed by a second TP from the same donor. A take of donor marrow cells now occurred and has persisted to the present (I40 days after TP). No evidence of graftversus-host disease was seen; PHA responsive peripheral blood lymphocytes have remained predominantly of host type. The patient has remained in excellent clinical health. Her B cell function is normalizing, but her T cell function is as yet depressed.
SUCCESSFUL MARROW RE-TRANSPLANTATION
SPLENIC FUNCTION AND HWTOLOGIC CHANGES DURING THE FIRST YEAR OF LIFE I N SICKLE CELL ANmIA. Richard T. O'Brien, Sue McIntosh, Gregg T. Aspnes and Howard A. Pearson, Dept. of Pediat r i c s , Yale Univ. Sch. of Med., New Haven, Conn.
Seven i n f a n t s with s i c k l e c e l l anemia have been i d e n t i f i e d i n routine screening of cord blood from 1500 neonates. These children have been followed s e r i a l l y f o r up t o 2 years. Hemoglobin l e v e l s f e l l most rapidly during t h e f i r s t 3 months and then declined more slowly, s t a b i l i z i n g between 7 and 10 gmX by 10 months of age. The post n a t a l decline of Hgb F was slower than normal but showed considerable v a r i a b i l i t y . There was close c o r r e l a t i o n between the r a t e of f a l l of Hgb F and t h e development and s e v e r i t y of hemolysis. C l i n i c a l vasocclusive s ptoms occurred a s e a r l y a s 4 months but were a l s o variable. 9 g T c c o l l o i d scans showed normal splenic a c t i v i t y i n a l l i n f a n t s before 6 months. The onset of functional asplenia was documented i n four i n f a n t s a t 7,8,10 and 11 months. Thus, functional asplenia i s an acquired defect i n s i c k l e c e l l anemia. Howell-Jolly bodies were noted p r i o r t o t h e abnormal scan. Functional asplenia occurred when Hgb F f e l l below 20%. Two i n f a n t s r e t a i n normal splenic function a t 12 and 20 months. These observations i n d i c a t e v a r i a b i l i t y i n the development of hematologic and splenic abnormalities i n children with homozygous Hgb S disease. The f a c t t h a t splenic dysfunction, with r e s u l t a n t s u s c e p t i b i l i t y t o overwhelming seps i s may occur a s e a r l y a s 7 months of age i n t h i s disease, provides impetus f o r e a r l y diagnosis. I n t h e red c e l l s from newborn i n f a n t s , 2,3-DPG declines more rapidly upon incubation than i t does i n t h e c e l l s from normal adults. The red c e l l s from 10 cord blood samples and 10 a d u l t s were incubated f o r 4 hours i n t h e presence o r absence of glucose (10 mM) , with f l u o r i d e (10 mM), o r iodoa c e t a t e (0.5 mM), t o determine i f impaired 2,3-DPG synthesis o r accelerated breakdown was responsible f o r t h e 2,3-DPG i n s t a b i l i t y . Assays of DPG mutase, t h e enzyme responsible f o r DPG synthesis, were a l s o performed on hemolysates.
I n t h e absence of glucose or i n t h e presence of IAA, a n inhibit o r t h a t a c t s proximal t o t h e point of DPG synthesis. DPG l e v e l s declined more rapidly i n t h e c e l l s of the newborn (0.82 !moles/ml/hr v s 0.50).
The n e t s y n t h e t i c r a t e s appeared similar, averaging 0.37 !.~moles/ml/hr i n t h e i n f a n t and 0.42 i n t h e a d u l t . Fluoride, an agent t h a t blocks glycol y s i s d i s t a l t o the s i t e of 2,3-DPG synthesis, produced a r i s e i n 2,3-DFC i n t h e c e l l s of a d u l t s (0.25 ymoles/ml/hr), while DPG l e v e l s declined i n t h e newborn. DPG m t a s e a c t iv i t y was s i m i l a r i n both i n f a n t s and a d u l t s . These findings suggest t h a t t h e DFC i n s t a b i l i t y observed i n the c e l l s of the i n f a n t is a r e s u l t of accelerated DPG breakdown and not a consequence of an impairment of glycolysis. The erythrocytes of normal a d u l t s have t h e capacity t o directed migration,and; 2) random, o r non-directed migration. W e incorporate and metabolize dihydroxyacetone (DHA) . This have a l s o shown t h a t neonatal PMNS a r e d e f i c i e n t i n chemos u b s t r a t e has been found t o be u s e f u l f o r t h e maintenance of t a x i s but have normal random m i g r a t i 0 n . h order t o f u r t h e r ' 2,3-diphosphoglycerate (DPG) i n stored red c e l l s . The characterize the nature of neonatal P M N movement,we have metabolism of DHA by cord blood erythrocytes was examined employed the study of membrane deformability.Using a microi n an attempt t o find a s u b s t r a t e f o r DPG synthesis t h a t manipulator,individual PMNS were directed t o the o r i f i c e of bypassed the e a r l y s t e p s i n red c e l l glycolysis. When t h e 3-5u i n t e r n a l diameter hollow glass pipettes.The "deformc e l l s from a d u l t s and i n f a n t s were incubated i n t h e prea b i l i t y " of t h e membrane was measured by the amount of negasence of DHA (10 mM), pyruvate (10 mM), and inorganic phost i v e pressure required t o draw the c e l l i n t o the pipette.The phate (10 mM), the DPG l e v e l increased by 2.34 !.~moles/ml assay i s precise and highly reproducible.Neonata1 PMNS showed RBC's i n t h e a d u l t samples but only increased by 0.1 umoles/ markedly decreased membrane deformability over control PMNSm l i n t h e c e l l s of i n f a n t s during a period of 2 hours. DHA i.e.,were much more r i g i d cells.The finding of a functional consumption averaged 3.76 pmoles/ml RBC1s/hr i n t h e c e l l s abnormality of the neonatal P M N membrane i s unique and has from a d u l t s but was only 1.16 pmoles/ml RBC1s/hr i n t h e major significance:l)Since neonatal PMNS a r e d e f i c i e n t i n erythrocytes of the newborn. Assays of triokinase, t h e chemotaxis but normal i n random mobility, membrane deformenzyme responsible f o r the phosphorylation of DHA, were a b i l i t y may play a r o l e i n chemotaxis.This i s supported by performed i n the hemolysates from newborn and a d u l t erythrothe observation t h a t iodoacetate,NaE and deoxyglucose,agents cytes. Triokinase a c t i v i t y averaged 4.56 + 0.69 units/100 which decrease membrane deformability also s e l e c t i v e l y m l RBC's i n a d u l t s and was only 2.97 + 0.54 u n i t s i n t h e i n h i b i t chemotaxis;2)PMN membrane deformability i s an a c t i v e c e l l s from newborns (p c.01). Relative t r i o k i n a s e process.The deformability defect here may,therefore,reflect d e f k i e n c y appears t o be another biochemical c h a r a c t e r i s t i c metabolic immaturity of the neonatal PMN.
of t h e red c e l l s of the newborn i n f a n t .
